Progress Against One Autoimmune Disease is Progress Against Them All

One in every 20 Americans suffers from an autoimmune disease—type 1 diabetes, multiple sclerosis, Crohn’s disease and rheumatoid arthritis are just a few. That’s why, at Benaroya Research Institute at Virginia Mason (BRI), our scientists aren’t focused on eliminating one or two autoimmune diseases—we’re taking on all 80. BRI is an international leader in autoimmune disease research and one of the few institutes dedicated to finding causes and cures to eliminate autoimmune diseases.


BRI Is:

  • A non-profit medical research institute in Seattle with 275 staff members, including 30 principal Investigators.
  • Unique in bringing together three arms of medical research – clinical research, translational research and laboratory research. Translational research takes laboratory discoveries from the bench to the bedside and back again.
  • A center of innovation for a variety of major consortia projects including the Immune Tolerance Network; the National Institutes of Health Autoimmunity Prevention Center and Type 1 Diabetes TrialNet; the Biomarker Core Center for JDRF and the T1D Exchange Biobank.

Primary Areas of Research


And many more...To see a full list and learn more about the fight against autoimmune diseases, visit BenaroyaResearch.org.


The First Tee of Greater Seattle

MISSION STATEMENT
The First Tee of Greater Seattle’s mission is to positively impact the lives of young people by providing learning facilities and educational programs that promote character-development and life-enhancing values through the game of golf. We serve kids from all backgrounds, ages 6 – 18 years old, and primarily target children who would not otherwise have access to the game of golf, including children from economically-disadvantaged backgrounds, girls and kids of color.